Загрузка...
Lipid-lowering agents in the management of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed countries and is associated not only with increased risk for liver disease-related complications but also with higher cardiovascular morbidity. Accordingly, lipid-lowering agents are frequently considered...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4209418/ https://ncbi.nlm.nih.gov/pubmed/25349644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i10.738 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|